A clinical study to investigate the effect of rosiglitazone, theophylline and inhaled corticosteroid, inflammation and pulmonary function in asthmatic smokers.

Trial Profile

A clinical study to investigate the effect of rosiglitazone, theophylline and inhaled corticosteroid, inflammation and pulmonary function in asthmatic smokers.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Rosiglitazone (Primary) ; Theophylline (Primary) ; Beclometasone
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Mar 2008 Additional trial identifier EudraCT2004-004247-22 added as reported by ClinicalTrials.gov.
    • 08 Nov 2007 Status changed from in progress to completed as reported on clinicaltrials.gov website.
    • 24 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top